Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Danisco Genencor Inc.

www.genencor.com

Latest From Danisco Genencor Inc.

Takeda strengthens cancer focus with Mersana ADC deal

Takeda is ramping up its presence in oncology, having signed a deal with antibody-drug conjugate (ADC) specialist Mersana Therapeutics via subsidiary Millennium Pharmaceuticals.

Infectious Diseases Cancer

Intrexon makes senior appointments

Synthetic biology company Intrexon has appointed Dr Glenn Nedwin president of its human therapeutics division and Mr Timothy Kasbe CIO of the company. Dr Nedwin has 30 years' experience including most recently VP at Danisco's Genencor. Mr Kasbe joins Intrexon from Sears Holdings where he was also CIO.

New appointment at Dendreon

Richard Ranieri has joined Dendreon (US) as senior vice-president of human resources. He most recently served as the executive vice-president of human resources and administration at Sepracor. He has also worked in human resources at Neurocrine Biosciences, Genencor International and SmithKline Beecham.

Companies

Presidio Pharmaceuticals makes appointment

Presidio Pharmaceuticals, a US speciality pharma company focused on the discovery, in-licensing, development and commercialisation of therapeutics for viral infections, including HIV-1 and hepatitis C, has named Tom Anderton vice-president of intellectual property and legal affairs. He previously served as associate general counsel at Monogram Biosciences. Before that, Mr Anderton was lead attorney, oncology, at Genencor.

Infectious Diseases Companies
See All

Company Information

  • Industry
  • Miscellaneous
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Genencor International Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Danisco Genencor Inc.
  • Senior Management
  • Jean-Jacques Bienaime, Chmn., Pres. & CEO
    Raymond J Land, SVP, CFO
  • Contact Info
  • Danisco Genencor Inc.
    Phone: (650) 846-7500
    925 Page Mill Road
    Palo Alto, CA 94304
    USA
UsernamePublicRestriction

Register